NTAP research initiatives are dedicated to ensuring that early discoveries are translated into effective treatments for plexiform neurofibromas (pNFs) and cutaneous neurofibromas (cNF) as efficiently as possible.
Our solicited proposals target key gaps in the understanding of pNFs and CNFs and accelerate the development of therapies against these tumors. In addition to funding the projects, NTAP supports up to 10% in indirect costs. Several times each year, NTAP announces new requests for proposals (RFPs) on this page and through announcements distributed through the scientific community.
Open solicited proposals:
NTAP is launching a new initiative to advancing meaningful therapeutic discovery for NF1 associated cNF informed by the outcomes of the 2022 cNF Symposium: the Biology and Therapeutic Development for Cutaneous Neurofibromas Initiative. A core element of this new cNF initiative is the Request of Applications for new research projects focused on cNF. We invite investigators and inventors from all scientific and clinical backgrounds, around the world, to respond to this request for applications HERE. The letters of intent for this opportunity are due August 5, 2022. Please review the full RFA for details about the application and funding.
Past solicited proposals:
- 01/01/2020: Opening the data drawers
- 04/19/2017: Understanding of Cutaneous Neurofibromas
- 03/15/2013: Development of Patient Reported Outcomes for Plexiform Neurofibromas
- 01/15/2013: Biomarker Development for Plexiform Neurofibroma
- 10/01/2012: Novel Cell Culture Model Systems of Plexiform Neurofibroma